Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LH | US
-1.12
-0.42%
Healthcare
Diagnostics & Research
30/06/2024
24/04/2026
263.80
264.93
266.06
262.56
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors hospitals pharmaceutical companies researchers and patients make clear and confident decisions. It operates in two segments Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests such as blood chemistry analyses urinalyses blood cell counts thyroid tests PAP tests hemoglobin A1C and vitamin D prostate-specific antigens tests for sexually transmitted diseases hepatitis C tests microbiology cultures and procedures and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases including anatomic pathology/oncology cardiovascular disease coagulation diagnostic genetics endocrinology infectious disease women's health pharmacogenetics and parentage and donor testing; occupational testing services medical drug monitoring services chronic disease programs and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs) including health fairs on-site and at-home testing vaccinations and health screenings. In addition the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development medical device and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs pharmaceutical biotechnology medical device and diagnostics companies governmental agencies physicians and other healthcare providers hospitals and health systems employers patients and consumers contract research organizations and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington North Carolina.
View LessLow 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
31.1%1 month
26.3%3 months
24.6%6 months
25.3%40.18
13.50
2.26
0.75
0.36
16.35
1.90
1.19
1.66B
22.15B
22.15B
1.33
9.51
14.60
6.20
5.36
3.42
2.97
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
21.91
Range1M
21.91
Range3M
34.22
Rel. volume
0.92
Price X volume
125.31M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Incorporated | DGX | Diagnostics & Research | 196.27 | 21.85B | -1.63% | 20.22 | 76.89% |
| Illumina Inc | ILMN | Diagnostics & Research | 127.88 | 20.37B | 1.95% | n/a | 203.41% |
| Waters Corporation | WAT | Diagnostics & Research | 309.87 | 18.39B | -0.43% | 34.84 | 147.93% |
| Medpace Holdings Inc | MEDP | Diagnostics & Research | 410.54 | 12.73B | 4.35% | 33.43 | 20.13% |
| Guardant Health Inc | GH | Diagnostics & Research | 88.91 | 10.94B | 1.18% | n/a | -83144.02% |
| RVTY | RVTY | Diagnostics & Research | 86.77 | 10.70B | -0.44% | 74.79 | 50.79% |
| Solventum Corp. | SOLV | Health Information Services | 68.52 | 10.03B | -0.64% | n/a | 311.02% |
| Charles River Laboratories International Inc | CRL | Diagnostics & Research | 169.8 | 8.77B | 1.23% | 23.63 | 76.32% |
| QIAGEN N.V | QGEN | Diagnostics & Research | 38.41 | 8.54B | 1.16% | 122.86 | 41.16% |
| ICON Public Limited Company | ICLR | Diagnostics & Research | 102.17 | 8.46B | -3.92% | 34.54 | 37.38% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Avery Dennison Corporation | AVY | Building Products & Equipment | 165.5 | 13.33B | -1.15% | 27.93 | 140.74% |
| Dolby Laboratories Inc | DLB | Media - Diversified | 64.08 | 6.11B | 1.78% | 34.32 | 0.00% |
| FBIN | FBIN | Building Products & Equipment | 41.54 | 5.16B | 0.34% | 25.57 | 130.24% |
| Thor Industries Inc | THO | Recreational Vehicles | 79 | 4.18B | 0.24% | 23.44 | 27.88% |
| Cinemark Holdings Inc | CNK | Media - Diversified | 28.48 | 3.49B | -0.42% | 27.93 | 934.91% |
| VeriFone Systems Inc | PAY | Building Products & Equipment | 27.25 | 3.39B | 0.96% | 102.46 | 2.10% |
| Polaris Industries Inc | PII | Recreational Vehicles | 60.04 | 3.35B | 1.06% | 14.48 | 170.51% |
| LCI Industries | LCII | Recreational Vehicles | 120.01 | 3.06B | -0.45% | 25.82 | 77.66% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 23.11 | 3.04B | -1.15% | 7.33 | 218.58% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 15.58 | 2.80B | 1.37% | n/a | -571.93% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 16.35 | 12.67 | Expensive |
| Ent. to Revenue | 1.90 | 44.00 | Cheaper |
| PE Ratio | 40.18 | 40.09 | Par |
| Price to Book | 2.26 | 77.50 | Cheaper |
| Dividend Yield | 1.33 | 1.18 | Par |
| Std. Deviation (3M) | 24.64 | 59.59 | Lower Risk |
| Debt to Equity | 0.75 | -14.36 | Expensive |
| Debt to Assets | 0.36 | 0.34 | Par |
| Market Cap | 22.15B | 13.71B | Market Leader |